Article Menu
Need Help?
No Article Versions Notes Found
Cite
Fung-Kee-Fung, M.; Oliver, T.; Elit, L.; Oza, A.; Hirte, H.W.; Bryson, P.; on behalf of the Gynecology Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care. Optimal Chemotherapy Treatment for Women with Recurrent Ovarian Cancer. Curr. Oncol. 2007, 14, 195-208. https://doi.org/10.3747/co.2007.148
Fung-Kee-Fung M, Oliver T, Elit L, Oza A, Hirte HW, Bryson P, on behalf of the Gynecology Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care. Optimal Chemotherapy Treatment for Women with Recurrent Ovarian Cancer. Current Oncology. 2007; 14(5):195-208. https://doi.org/10.3747/co.2007.148
Chicago/Turabian StyleFung-Kee-Fung, M., T. Oliver, L. Elit, A. Oza, H. W. Hirte, P. Bryson, and on behalf of the Gynecology Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care. 2007. "Optimal Chemotherapy Treatment for Women with Recurrent Ovarian Cancer" Current Oncology 14, no. 5: 195-208. https://doi.org/10.3747/co.2007.148
APA StyleFung-Kee-Fung, M., Oliver, T., Elit, L., Oza, A., Hirte, H. W., Bryson, P., & on behalf of the Gynecology Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care. (2007). Optimal Chemotherapy Treatment for Women with Recurrent Ovarian Cancer. Current Oncology, 14(5), 195-208. https://doi.org/10.3747/co.2007.148
